Shanxi Zhendong Pharmaceutical Co.,Ltd

¥4.79As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300158Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (3.66%)
Div yield —
ROE (14.68%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.24
PE TTM —
TSR TTM (31.38%)
Mkt cap ¥4.753B
ROIC (18.54%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥4.78
(0.12%)
(73.24%)
Hold 4|9|5|4|6
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.09
0.09
0.09
0.09
15.47%
15.62%
21.70%
10.28%
Revenue¥M
255.9
265.2
271.2
274.8
6.54%
10.23%
7.05%
8.54%
Peers (US$712.5M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
0.825
1.763
1.496
EBIT/Intx
0.442
0.247
0.271
Own earn%
(15.66)
(95.19)
(77.19)
Sh yield%
38.17
29.66
30.60
Owners
Insiders/Inst%
0.43
70.53
Short interest%
2.55
SBC / revenue%
3.46
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
20
Op margin range%
10–15
$1 testx
—
Incr. ROIC%
11